Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Mandala Multifinance Tbk. (MFIN) Price & Performance

UBC Medical Indonesia Tbk.Trade
Mandala Multifinance Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Mandala Multifinance Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Mandala Multifinance Tbk. trades at Rp890 (market cap 4.45T). The key difference: Mandala Multifinance Tbk. is far larger — about 6.4× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

LABSMFIN
Market Cap
691.25B4.45T
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MFIN
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Mandala Multifinance Tbk.

PT Mandala Multifinance Tbk (the Company) was established under its original name of PT Vidya Cipta Leasing Corporation on Aug 13th, 1983, then changed to PT Lautan Berlian Leasing at 1990. On 1996 company's name changed to PT Gracia Dinamika Mulifinance and in 1997 the name changed to PT Mandala Multifinance.The articles of association has been amended most recently by notarial deed no 34 dated 28 Apr 2005 concerning among others, the change in the company's name and public offering of stock.

Read more on MFIN